Vladislav Strmiska

1.0k total citations · 1 hit paper
18 papers, 621 citations indexed

About

Vladislav Strmiska is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Vladislav Strmiska has authored 18 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Biomaterials and 4 papers in Biomedical Engineering. Recurrent topics in Vladislav Strmiska's work include Nanoparticle-Based Drug Delivery (4 papers), Nanoparticles: synthesis and applications (3 papers) and Epigenetics and DNA Methylation (2 papers). Vladislav Strmiska is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Nanoparticles: synthesis and applications (3 papers) and Epigenetics and DNA Methylation (2 papers). Vladislav Strmiska collaborates with scholars based in Czechia, Austria and Poland. Vladislav Strmiska's co-authors include Marcin Braun, Piotr Siciński, Jan M. Suski, Vojtěch Adam, Zbyněk Heger, Stanislava Voběrková, Ana Maria Jimenez Jimenez, Martina Vršanská, Petr Michálek and Soňa Křížková and has published in prestigious journals such as Cancer Cell, Journal of Hazardous Materials and Scientific Reports.

In The Last Decade

Vladislav Strmiska

18 papers receiving 613 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting cell-cycle machinery in cancer

2021 350 citations Jan M. Suski, Marcin Braun et al. Cancer Cell profile →

Peers

Countries citing papers authored by Vladislav Strmiska

Since Specialization

Citations

This map shows the geographic impact of Vladislav Strmiska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vladislav Strmiska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vladislav Strmiska more than expected).

Fields of papers citing papers by Vladislav Strmiska

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vladislav Strmiska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vladislav Strmiska. The network helps show where Vladislav Strmiska may publish in the future.

Co-authorship network of co-authors of Vladislav Strmiska

This figure shows the co-authorship network connecting the top 25 collaborators of Vladislav Strmiska. A scholar is included among the top collaborators of Vladislav Strmiska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vladislav Strmiska. Vladislav Strmiska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Targeting cell-cycle machinery in cancer breakdown → 2021 ·Cancer Cell ·Jan M. Suski, Marcin Braun, Vladislav Strmiska, Piotr Siciński	350
2	Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma 2021 ·Scientific Reports ·Miguel Ángel Merlos Rodrigo, Hana Michalkova, Vladislav Strmiska, Berta Casar, Piero Crespo, Vivian de los Rı́os, J. Ignacio Casal, Yazan Haddad, Roman Guráň, Tomáš Eckschlager, Petra Pokorná, Zbyněk Heger, Vojtěch Adam	17
3	Complex cytotoxicity mechanism of bundles formed from self-organised 1-D anodic TiO2 nanotubes layers 2020 ·Journal of Hazardous Materials ·Hana Michalkova, (unknown), Hanna Sopha, Vladislav Strmiska, (unknown), Simona Dostálová, P Svec, Luděk Hromádko, Martin Motola, Jan M. Macák, Vojtěch Adam, Zbyněk Heger	22
4	Soil protein as a potential antimicrobial agent against methicillin –resistant Staphylococcus aureus 2020 ·Environmental Research ·(unknown), Miguel Ángel Merlos Rodrigo, (unknown), Vladislav Strmiska, Zbyněk Šplíchal, Nico Jehmlich, Hana Michalkova, Marko Stojanović, Stanislava Voběrková, Vojtěch Adam, Amitava Moulick	4
5	<p>Tuning the surface coating of IONs toward efficient sonochemical tethering and sustained liberation of topoisomerase II poisons</p> 2019 ·International Journal of Nanomedicine ·Hana Michalkova, Vladislav Strmiska, Jiří Kudr, (unknown), (unknown), P Svec, Lukáš Richtera, Ondřej Zítka, Vojtěch Adam, Zbyněk Heger	3
6	Prevalent anatase crystalline phase increases the cytotoxicity of biphasic titanium dioxide nanoparticles in mammalian cells 2019 ·Colloids and Surfaces B Biointerfaces ·(unknown), Hana Michalkova, Petr Michálek, Vladislav Strmiska, Roman Guráň, Miguel Ángel Merlos Rodrigo, Klára Částková, David Hynek, Vladimír Pekařík, Ondřej Zítka, Vojtěch Adam, Zbyněk Heger	9
7	Sarcosine is a prostate epigenetic modifier that elicits aberrant methylation patterns through the SAMe‐Dnmts axis 2019 ·Molecular Oncology ·Vladislav Strmiska, Petr Michálek, (unknown), Roman Guráň, Soňa Křížková, Lucie Vaníčková, Ondřej Zítka, Marie Stiborová, Tomáš Eckschlager, Bořivoj Klejdus, Dalibor Pacík, (unknown), Claudia Keil, Hajo Haase, Vojtěch Adam, Zbyněk Heger	13
8	One-step detection of human papilloma viral infection using quantum dot-nucleotide interaction specificity 2019 ·Talanta ·Ana Maria Jimenez Jimenez, Amitava Moulick, (unknown), Vladislav Strmiska, Milica Gagić, (unknown), Rom Kostřica, Michal Masařík, Zbyněk Heger, Vojtěch Adam	9
9	Prostate cancer-specific hallmarks of amino acids metabolism: Towards a paradigm of precision medicine 2019 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Vladislav Strmiska, Petr Michálek, Tomáš Eckschlager, Marie Stiborová, Vojtěch Adam, Soňa Křížková, Zbyněk Heger	44
10	Identification of Sarcosine as a Target Molecule for the Canine Olfactory Detection of Prostate Carcinoma 2018 ·Scientific Reports ·Dalibor Pacík, (unknown), (unknown), (unknown), Vladislav Strmiska, Alois Nečas, Zbyněk Heger, Vojtěch Adam	9
11	Post‐treatment urinary sarcosine as a predictor of recurrent relapses in patients with prostate cancer 2018 ·Cancer Medicine ·Jaromír Gumulec, Martina Raudenská, Dalibor Pacík, (unknown), (unknown), (unknown), Natalia Cernei, Vladislav Strmiska, Ondřej Zítka, Zbyněk Heger, Vojtěch Adam	3
12	Synthesis and structural characterization of antimicrobial binuclear copper(II) coordination compounds bridged by hydroxy- and/or thiodipropionic acid 2018 ·Journal of Inorganic Biochemistry ·(unknown), (unknown), Vladislav Strmiska, Petr Michálek, Silvia Kočiová, Kristýna Šmerková, R. Kruszyński, Alina Bieńko, (unknown), Agnieszka Lewińska, Dariusz C. Bieńko, Magdalena Malik, Vedran Milosavljević, Pavel Kopel, Zbyněk Heger, Vojtěch Adam	6
13	Improving cytocompatibility of CdTe quantum dots by Schiff-base-coordinated lanthanides surface doping 2018 ·Journal of Nanobiotechnology ·(unknown), Vladislav Strmiska, (unknown), Simona Dostálová, Petr Michálek, Soňa Křížková, David Hynek, Lukáš Kalina, Lukáš Richtera, Amitava Moulick, Vojtěch Adam, Zbyněk Heger	10
14	Size-related cytotoxicological aspects of polyvinylpyrrolidone-capped platinum nanoparticles 2017 ·Food and Chemical Toxicology ·(unknown), Simona Dostálová, Petr Michálek, Soňa Křížková, Vladislav Strmiska, Pavel Kopel, David Hynek, Lukáš Richtera, Andrea Ridošková, (unknown), Jindřích Kynický, Martin Brtnický, Zbyněk Heger, Vojtěch Adam	25
15	Preparation and Optimisation of Cross-Linked Enzyme Aggregates Using Native Isolate White Rot Fungi Trametes versicolor and Fomes fomentarius for the Decolourisation of Synthetic Dyes 2017 ·International Journal of Environmental Research and Public Health ·Martina Vršanská, Stanislava Voběrková, Ana Maria Jimenez Jimenez, Vladislav Strmiska, Vojtěch Adam	77
16	pH-Responsive Hybrid Organic-Inorganic Ruthenium Nanoparticles for Controlled Release of Doxorubicin 2017 ·Particle & Particle Systems Characterization ·(unknown), Vladislav Strmiska, Simona Dostálová, Petr Michálek, Soňa Křížková, Pavel Kopel, David Hynek, Lukáš Richtera, Vojtěch Adam, Zbyněk Heger	4
17	Comparative gene expression profiling of human metallothionein-3 up-regulation in neuroblastoma cells and its impact on susceptibility to cisplatin 2017 ·Oncotarget ·Miguel Ángel Merlos Rodrigo, Simona Dostálová, (unknown), Vladislav Strmiska, Petr Michálek, Soňa Křížková, Aleš Vícha, (unknown), Tomáš Eckschlager, Marie Stiborová, Zbyněk Heger, Vojtěch Adam	8
18	Sarcosine influences apoptosis and growth of prostate cells via cell‐type specific regulation of distinct sets of genes 2017 ·The Prostate ·Miguel Ángel Merlos Rodrigo, Vladislav Strmiska, (unknown), (unknown), Petr Michálek, Marie Stiborová, Tomáš Eckschlager, Vojtěch Adam, Zbyněk Heger	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact